SI3168214T1 - Substituiran 2-tiokso-imidazolidin-4-on in njegovi spiro analogi, aktivne proti rakave sestavine, farmacevtski sestavki, medicinski pripravki, postopek za zdravljenje raka prostate - Google Patents
Substituiran 2-tiokso-imidazolidin-4-on in njegovi spiro analogi, aktivne proti rakave sestavine, farmacevtski sestavki, medicinski pripravki, postopek za zdravljenje raka prostateInfo
- Publication number
- SI3168214T1 SI3168214T1 SI201530801T SI201530801T SI3168214T1 SI 3168214 T1 SI3168214 T1 SI 3168214T1 SI 201530801 T SI201530801 T SI 201530801T SI 201530801 T SI201530801 T SI 201530801T SI 3168214 T1 SI3168214 T1 SI 3168214T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cancer
- imidazolidin
- thioxo
- ones
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/16—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014127705/04A RU2557235C1 (ru) | 2014-07-08 | 2014-07-08 | Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты |
| PCT/RU2015/000395 WO2016007046A1 (ru) | 2014-07-08 | 2015-06-26 | Замещенные 2-тиоксо-имидазолидин-4-оны и их спироаналоги, противораковый активный компонент, фармацевтическая композиция, лекарственный препарат, способ лечения рака простаты |
| EP15818878.9A EP3168214B1 (en) | 2014-07-08 | 2015-06-26 | Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anti-cancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3168214T1 true SI3168214T1 (sl) | 2019-09-30 |
Family
ID=53611746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201530801T SI3168214T1 (sl) | 2014-07-08 | 2015-06-26 | Substituiran 2-tiokso-imidazolidin-4-on in njegovi spiro analogi, aktivne proti rakave sestavine, farmacevtski sestavki, medicinski pripravki, postopek za zdravljenje raka prostate |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10450278B2 (sl) |
| EP (1) | EP3168214B1 (sl) |
| JP (1) | JP6581193B2 (sl) |
| KR (1) | KR102171120B1 (sl) |
| AU (1) | AU2015288381B2 (sl) |
| CA (1) | CA2954401C (sl) |
| CY (1) | CY1122231T1 (sl) |
| DK (1) | DK3168214T3 (sl) |
| ES (1) | ES2736507T3 (sl) |
| GE (1) | GEP20207096B (sl) |
| HR (1) | HRP20191265T8 (sl) |
| HU (1) | HUE044317T2 (sl) |
| LT (1) | LT3168214T (sl) |
| PL (1) | PL3168214T3 (sl) |
| PT (1) | PT3168214T (sl) |
| RS (1) | RS59009B1 (sl) |
| RU (1) | RU2557235C1 (sl) |
| SI (1) | SI3168214T1 (sl) |
| SM (1) | SMT201900379T1 (sl) |
| TR (1) | TR201910220T4 (sl) |
| UA (1) | UA117626C2 (sl) |
| WO (1) | WO2016007046A1 (sl) |
| ZA (1) | ZA201700922B (sl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3030181A1 (en) * | 2016-07-08 | 2018-01-11 | Janssen Pharmaceutica Nv | Substituted hydantoin and thiohydantoin derivatives as androgen receptor antagonists |
| CN107954936B (zh) * | 2016-10-17 | 2021-03-19 | 海创药业股份有限公司 | 一种制备氘代咪唑二酮类化合物的方法 |
| CN109422725A (zh) * | 2017-09-04 | 2019-03-05 | 北京美倍他药物研究有限公司 | 前列腺癌治疗药物 |
| RU2708253C2 (ru) * | 2017-12-05 | 2019-12-05 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) | Новые производные арил-тиогидантоина, ингибиторы андрогенового рецептора, способ получения и применения |
| KR102864064B1 (ko) | 2018-12-19 | 2025-09-24 | 셀진 코포레이션 | 치환된 3-((3-아미노페닐)아미노)피페리딘-2,6-디온 화합물, 이의 조성물, 및 이를 사용한 치료 방법 |
| FI3897636T3 (fi) * | 2018-12-19 | 2025-02-03 | Celgene Corp | Substituoituja 3-((3-aminofenyyli)amino)piperidiini-2,6-dioniyhdisteitä, niiden koostumuksia ja menetelmiä niillä annettavia hoitoja varten |
| CN114621109B (zh) * | 2020-12-14 | 2024-04-26 | 成都苑东生物制药股份有限公司 | 一种阿帕他胺的合成方法及其中间体 |
| CN113698310B (zh) * | 2021-08-20 | 2023-03-17 | 江西金丰药业有限公司 | 一种恩杂鲁胺双酯中间体的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS52274B2 (sr) * | 2005-05-13 | 2018-05-31 | Univ California | Jedinjenje diarilhidantoina |
| SG10201402628VA (en) * | 2009-02-24 | 2014-10-30 | Medivation Prostate Therapeutics Inc | Specific Diarylhydantoin And Diarylthiohydantoin Compounds |
| EA028869B1 (ru) * | 2010-02-16 | 2018-01-31 | Арагон Фармасьютикалс, Инк. | Модуляторы рецептора андрогенов и их применение |
| EP2538785B1 (en) * | 2010-02-24 | 2018-03-21 | Medivation Prostate Therapeutics LLC | Processes for the synthesis of diarylthiohydantoin and diarylhydantoin compounds |
| RU2434851C1 (ru) | 2010-07-22 | 2011-11-27 | Александр Васильевич Иващенко | Циклические n, n'-диарилтиомочевины или n, n'-диарилмочевины - антагонисты андрогенных рецепторов, противораковое средство, способ получения и применения |
| RU2520134C1 (ru) * | 2013-02-27 | 2014-06-20 | Общество с ограниченной ответственностью "Авионко" (ООО "Авионко") | Замещенные (r)-3-(4-метилкарбамоил-3-фторфениламино)-тетрагидро-фуран-3-енкарбоновые кислоты и их эфиры, способ их получения и применения |
-
2014
- 2014-07-08 RU RU2014127705/04A patent/RU2557235C1/ru active
-
2015
- 2015-06-26 GE GEAP201514411A patent/GEP20207096B/en unknown
- 2015-06-26 SM SM20190379T patent/SMT201900379T1/it unknown
- 2015-06-26 SI SI201530801T patent/SI3168214T1/sl unknown
- 2015-06-26 US US15/324,658 patent/US10450278B2/en active Active
- 2015-06-26 RS RS20190891A patent/RS59009B1/sr unknown
- 2015-06-26 EP EP15818878.9A patent/EP3168214B1/en active Active
- 2015-06-26 PL PL15818878T patent/PL3168214T3/pl unknown
- 2015-06-26 LT LTEP15818878.9T patent/LT3168214T/lt unknown
- 2015-06-26 ES ES15818878T patent/ES2736507T3/es active Active
- 2015-06-26 HU HUE15818878 patent/HUE044317T2/hu unknown
- 2015-06-26 HR HRP20191265T patent/HRP20191265T8/hr unknown
- 2015-06-26 DK DK15818878.9T patent/DK3168214T3/da active
- 2015-06-26 AU AU2015288381A patent/AU2015288381B2/en active Active
- 2015-06-26 KR KR1020177003384A patent/KR102171120B1/ko active Active
- 2015-06-26 CA CA2954401A patent/CA2954401C/en not_active Expired - Fee Related
- 2015-06-26 WO PCT/RU2015/000395 patent/WO2016007046A1/ru not_active Ceased
- 2015-06-26 UA UAA201700635A patent/UA117626C2/uk unknown
- 2015-06-26 PT PT15818878T patent/PT3168214T/pt unknown
- 2015-06-26 TR TR2019/10220T patent/TR201910220T4/tr unknown
- 2015-06-26 JP JP2017522315A patent/JP6581193B2/ja active Active
-
2017
- 2017-02-06 ZA ZA2017/00922A patent/ZA201700922B/en unknown
-
2019
- 2019-07-15 CY CY20191100752T patent/CY1122231T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA201700922B (en) | 2019-08-28 |
| TR201910220T4 (tr) | 2019-07-22 |
| EP3168214A4 (en) | 2018-02-14 |
| GEP20207096B (en) | 2020-04-10 |
| KR102171120B1 (ko) | 2020-10-29 |
| HUE044317T2 (hu) | 2019-10-28 |
| EP3168214A1 (en) | 2017-05-17 |
| PT3168214T (pt) | 2019-07-25 |
| SMT201900379T1 (it) | 2019-09-09 |
| RS59009B1 (sr) | 2019-08-30 |
| WO2016007046A1 (ru) | 2016-01-14 |
| HRP20191265T8 (hr) | 2019-11-01 |
| UA117626C2 (uk) | 2018-08-27 |
| CA2954401C (en) | 2021-03-02 |
| DK3168214T3 (da) | 2019-07-22 |
| CA2954401A1 (en) | 2016-01-14 |
| RU2557235C1 (ru) | 2015-07-20 |
| KR20170023184A (ko) | 2017-03-02 |
| EP3168214B1 (en) | 2019-04-24 |
| CY1122231T1 (el) | 2020-11-25 |
| LT3168214T (lt) | 2019-07-25 |
| PL3168214T3 (pl) | 2019-10-31 |
| JP2017522379A (ja) | 2017-08-10 |
| US20180179164A1 (en) | 2018-06-28 |
| JP6581193B2 (ja) | 2019-09-25 |
| US10450278B2 (en) | 2019-10-22 |
| AU2015288381B2 (en) | 2019-11-07 |
| AU2015288381A1 (en) | 2017-03-02 |
| ES2736507T3 (es) | 2020-01-02 |
| HRP20191265T1 (hr) | 2019-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201700922B (en) | Substituted 2-thioxo-imidazolidin-4-ones and spiro analogues thereof, active anti-cancer ingredient, pharmaceutical composition, medicinal preparation, method for treating prostate cancer | |
| EP3263135A4 (en) | Pharmaceutical composition for treating cancer comprising microrna as active ingredient | |
| ZA201802303B (en) | Pharmaceutical composition containing anionic drug, and preparation method therefor | |
| GB201411465D0 (en) | Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer | |
| LT3224254T (lt) | Pakeistieji indazolai, jų gavimo būdas, juos turinčios farmacinės kompozicijos ir jų panaudojimas vaistų gamybai | |
| EP3222278A4 (en) | Use of azelnidipine in preparing medicinal composition for treating cancers | |
| PL3311375T3 (pl) | Urządzenia i sposoby podawania i mieszania leków oraz szkolenie w zakresie odpowiednich technik | |
| SG11201605868XA (en) | Pharmaceutical composition for cancer treatment and pharmaceutical preparation for cancer treatment containing same composition as active ingredient | |
| PL3391893T3 (pl) | Kompozycja farmaceutyczna do leczenia białaczki i sposób jej przygotowania | |
| SG11201610636VA (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
| EP3202417A4 (en) | Vaccine pharmaceutical composition for transdermal administration | |
| EP3295949A4 (en) | Topical drug for treating breast cancer and preparation method thereof | |
| EP3100744A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| IL249860A0 (en) | Pharmaceutical preparations, methods for their preparation and their use for the treatment of cancer | |
| GB201621559D0 (en) | A method for the preparation of a delivery drug delivery system and a composition therefor | |
| HUE050488T2 (hu) | Gyógyszerek rekonstituálására és beadására szolgáló eszköz | |
| GB201608315D0 (en) | Device for delivering medicaments or active ingredients | |
| GB201519644D0 (en) | Therapy and pharmaceutical composition | |
| EP3100743A4 (en) | Composition for accelerating penetration through skin, preparation for transdermal administration, and skin patch preparation | |
| GB201414271D0 (en) | Composition for delivery of an active pharmaceutical substance and method of preparing same |